Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study

Author:

Sionis Alessandro1,Rivas-Lasarte Mercedes1ORCID,Mebazaa Alexandre2,Tarvasmäki Tuukka34ORCID,Sans-Roselló Jordi1,Tolppanen Heli45,Varpula Marjut4,Jurkko Raija4,Banaszewski Marek6,Silva-Cardoso Jose7,Carubelli Valentina8,Lindholm Matias Greve9,Parissis John10,Spinar Jindrich11,Lassus Johan4,Harjola Veli-Pekka3,Masip Josep12

Affiliation:

1. Cardiology Department, Intensive Cardiac Care Unit, Hospital de la Santa Creu i Sant Pau, IIB-SantPau, CIBER-CV, Universidad Autònoma de Barcelona, Barcelona, Spain

2. INSERM U942, Hopital Lariboisiere, APHP and University Paris Diderot, Paris, France

3. Emergency Medicine, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland

4. Heart and Lung Center, Helsinki University and Helsinki University Hospital, Helsinki, Finland

5. Heart Center, Päijät-Häme Central Hospital, Lahti, Finland

6. Institute of Cardiology, Intensive Cardiac Therapy Clinic, Warsaw, Poland

7. Department of Cardiology, Faculty of Medicine, CINTESIS—Center for Health Technology and Services Research, University of Porto, São João Medical Center, Porto, Portugal

8. Division of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University and Civil Hospital of Brescia, Brescia, Italy

9. Division of Heart Failure, Pulmonary Hypertension and Heart Transplantation, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

10. Heart Failure Clinic and Secondary Cardiology Department, Attikon University Hospital, Athens, Greece

11. Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic

12. Critical Care Department, Hospital Sant Joan Despi Moisès Broggi, Consorci Sanitari Integral, University of Barcelona, Barcelona, Spain

Abstract

Background: Cardiogenic shock (CS) is the most life-threatening manifestation of acute heart failure. Its complexity and high in-hospital mortality may justify the need for invasive monitoring with a pulmonary artery catheter (PAC). Methods: Patients with CS included in the CardShock Study, an observational, prospective, multicenter, European registry, were analyzed, aiming to describe the real-world use of PAC, evaluate its impact on 30-day mortality, and the ability of different hemodynamic parameters to predict outcomes. Results: Pulmonary artery catheter was used in 82 (37.4%) of the 219 patients. Cardiogenic shock patients who managed with a PAC received more frequently treatment with inotropes and vasopressors, mechanical ventilation, renal replacement therapy, and mechanical assist devices ( P < .01). Overall 30-day mortality was 36.5%. Pulmonary artery catheter use did not affect mortality even after propensity score matching analysis (hazard ratio = 1.17 [0.59-2.32], P = .66). Cardiac index, cardiac power index (CPI), and stroke volume index (SVI) showed the highest areas under the curve for 30-day mortality (ranging from 0.752-0.803) and allowed for a significant net reclassification improvement of 0.467 (0.083-1.180), 0.700 (0.185-1.282), 0.683 (0.168-1.141), respectively, when added to the CardShock risk score. Conclusions: In our contemporary cohort of CS, over one-third of patients were managed with a PAC. Pulmonary artery catheter use was associated with a more aggressive treatment strategy. Nevertheless, PAC use was not associated with 30-day mortality. Cardiac index, CPI, and SVI were the strongest 30-day mortality predictors on top of the previously validated CardShock risk score.

Funder

Finnish Cardiac Foundation

syöpäsäätiö

academy of finland

wilhelm och else stockmanns stiftelse

Paavo Nurmen Säätiö

Orionin Tutkimussäätiö

Ida Montinin Säätiö

Finska Läkaresällskapet

Aarne Koskelon Säätiö

Publisher

SAGE Publications

Subject

Critical Care and Intensive Care Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3